AI Ultrasound Lets Novices Scan Like Pros, Aims to Transform ER Care

CHARLOTTESVILLE, VA – April 29, 2026 – A groundbreaking study has demonstrated that non-physician hospital staff, with just a single hour of training, can capture diagnostic-quality images of wrist and ankle injuries using a new AI-powered ultrasound system. The findings, centered on RIVANNA's Accuro XV device, suggest a potential paradigm shift in how crowded emergency departments manage common injuries, promising to slash wait times and optimize the use of highly trained medical personnel.

The study, published in the Journal of Emergency Medicine, validates a core premise of the technology: that complex medical imaging can be simplified through automation and artificial intelligence, effectively placing a powerful diagnostic tool into more hands.

A Landmark Study in Usability

The research, led by investigators from UVA Health and UT Southwestern Medical Center, was designed to test a simple but critical question: could the Accuro XV system eliminate the steep learning curve traditionally associated with ultrasound? The answer appears to be a resounding yes.

In the study, 205 patients with acute wrist or ankle injuries were scanned by two different groups of operators: board-certified emergency physicians and clinical research assistants (CRAs) with no prior sonography experience. Crucially, both groups received the exact same one-hour hands-on training session on the Accuro XV.

When a blinded panel of reviewers assessed the resulting images, they found no statistically significant difference in quality between the scans taken by physicians and those taken by the newly trained CRAs. More than 90% of scans from both groups were deemed adequate for making a medical diagnosis. The system's automated, guided process effectively leveled the playing field, enabling novices to perform on par with experts after minimal instruction.

"In our study, staff with minimal ultrasound training were able to acquire interpretable wrist and ankle scans with the Accuro XV, and patients reported little additional discomfort," said Dr. Christopher Thom, lead study author and Associate Professor of Emergency Medicine at the University of Virginia School of Medicine. "In high-volume emergency departments, the ability to delegate imaging tasks to trained support staff could meaningfully improve patient throughput and help deploy clinical teams more efficiently."

Breaking Down Barriers in Point-of-Care Diagnostics

The findings address one of the most significant hurdles to the widespread adoption of point-of-care ultrasound (POCUS): operator dependency. While portable ultrasound devices from companies like GE Healthcare and Philips have become smaller and more powerful, using them effectively has traditionally required hundreds of hours of training and practice to master the hand-eye coordination needed to acquire and interpret images.

RIVANNA's system tackles this challenge head-on. The Accuro XV uses a novel three-dimensional probe that automates the scanning process over a large area. The operator is guided along a predefined path, ensuring the capture of a standardized, comprehensive volumetric dataset. This removes the variability and guesswork that can frustrate inexperienced users, ensuring consistent results regardless of who is holding the probe.

This ease of use has profound implications for hospital workflow. Instead of waiting for a physician or a specialized sonographer to become available, a trained medical assistant or technician could perform the initial scan on a patient with a sprained ankle or a suspected wrist fracture. This would provide the attending physician with diagnostic images much faster, allowing for quicker triage decisions and freeing up the physician to focus on more critically ill patients. It represents a move from a model where the expert must perform every step to one where technology empowers the entire care team.

A Glimpse into an AI-Driven Future

While the study focused on image acquisition, RIVANNA's long-term vision extends to automating the entire diagnostic pipeline. The Accuro XV platform is being developed with two key AI-powered software modules that are currently advancing toward FDA clearance.

The first, BoneEnhance®, is designed to automatically segment the bone from surrounding soft tissue in the ultrasound data, creating a clean, 3D-like view of the skeletal structure that is easier to interpret than traditional B-mode ultrasound images.

The second, a computer-aided detection module known as CADe/x, will use machine learning algorithms to automatically identify and highlight potential fractures. This would provide clinicians with an immediate "second opinion," helping to triage low-severity injuries and decide whether a follow-up X-ray is even necessary. This is particularly significant as it offers a path to reducing patient exposure to ionizing radiation, a key advantage over the current standard of care.

This combination of automated acquisition and AI-assisted interpretation positions the Accuro XV not just as an imaging device, but as a comprehensive clinical decision-support solution designed for the fast-paced, high-pressure environment of emergency medicine.

A Strategic Asset for National Health Security

The transformative potential of the Accuro XV has not gone unnoticed by the federal government. The project is backed by a substantial contract from the Biomedical Advanced Research and Development Authority (BARDA), an agency within the U.S. Department of Health and Human Services tasked with developing and procuring medical countermeasures for public health emergencies.

The contract, with a potential value of over $50 million, underscores the system's strategic importance beyond daily hospital use. BARDA sees the technology as a critical tool for mass-casualty scenarios, such as natural disasters or terrorist attacks, where local healthcare systems could be instantly overwhelmed with extremity injuries. A portable, easy-to-use device that can rapidly triage fractures without relying on limited X-ray machines or specialized staff could be invaluable in such a crisis.

This federal support is accelerating the development and validation of the platform's AI capabilities, with an expanded multi-site clinical study currently underway to gather the vast amounts of data needed to train and test the fracture-detection algorithms. By supporting this technology, the government is investing in a more resilient and responsive national healthcare infrastructure, capable of scaling up diagnostic capabilities at a moment's notice. As future studies focus on diagnostic accuracy and real-world clinical impact, the Accuro XV is poised to redefine the front lines of musculoskeletal injury care.